Thursday 24 April 2014
 
» Projects » NucleiPark » Scientific motivation » Selection and evaluation of the patients
 
Selection and evaluation of the patients

 

Parkinson’s disease (with RBD, with gait and balance troubles, without any of those) and PSP (with ocular supranuclear palsy, axial parkinsonism unresponsive to L-Dopa and postural instability and falls) will be compared to age-matched normal controls. Patients will be selected from the Movement Disorders clinic (M Vidailhet, D Grabli, E Roze) according to the UK Parkinson’s disease brain bank criteria (Parkinson) or the Litvan’s NINDS criteria (PSP).

Clinical evaluation will be performed in the Clinical Investigation Centre Pitié-Salpêtrière, Paris including quantification of parkinsonian symptoms severity (UPDRS), cognitive functions, characterization of RBD (questionnaire and polysomnography, Dr I Arnulf), electrophysiological quantification of gait and balance parameters (Dr ML Welter, Dr C Ewenczyk). PSP patients will have eye movement recordings (EMR) All patients will have genetic tests.

 
 
Published on Tuesday 6 October 2009

 
 
 
The others articles in the same section :
 
Published on Tuesday 6 October 2009
 
Published on Tuesday 6 October 2009
Update Monday 8 March 2010
 
Published on Tuesday 6 October 2009
 
Published on Tuesday 6 October 2009
 
Published on Tuesday 6 October 2009
 

 
Home     |    Site Map     |    Editors area     |    Login
  Mis à jour le vendredi 21 mars 2014